Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
1.23
Dollar change
-0.06
Percentage change
-4.65
%
Index- P/E- EPS (ttm)-13.34 Insider Own0.02% Shs Outstand2.45M Perf Week-22.64%
Market Cap3.01M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.45M Perf Month-43.58%
Income-5.12M PEG- EPS next Q- Inst Own2.56% Short Float6.96% Perf Quarter-63.06%
Sales2.88M P/S1.05 EPS this Y- Inst Trans- Short Ratio0.13 Perf Half Y-78.79%
Book/sh10.77 P/B0.11 EPS next Y- ROA-47.02% Short Interest0.17M Perf Year-91.84%
Cash/sh2.10 P/C0.59 EPS next 5Y- ROE-72.84% 52W Range1.27 - 23.66 Perf YTD-74.80%
Dividend Est.- P/FCF- EPS past 5Y-55.28% ROI-67.06% 52W High-94.80% Beta1.32
Dividend TTM- Quick Ratio3.63 Sales past 5Y22.75% Gross Margin47.12% 52W Low-3.15% ATR (14)0.21
Dividend Ex-Date- Current Ratio4.10 EPS Y/Y TTM61.54% Oper. Margin-220.81% RSI (14)21.00 Volatility6.47% 7.89%
Employees4 Debt/Eq0.01 Sales Y/Y TTM113.73% Profit Margin-177.91% Recom1.00 Target Price520.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q- Payout- Rel Volume0.12 Prev Close1.29
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume1.33M Price1.23
SMA20-28.95% SMA50-55.16% SMA200-77.39% Trades Volume153,824 Change-4.65%
Apr-11-24 08:15AM
Mar-27-24 09:12AM
08:55AM
Mar-21-24 08:58AM
Mar-18-24 07:29AM
08:49AM Loading…
Mar-14-24 08:49AM
Mar-12-24 08:14AM
Mar-08-24 07:11AM
Mar-07-24 07:49AM
Mar-06-24 04:41PM
Feb-29-24 08:35AM
Feb-27-24 09:30AM
07:58AM
07:58AM
Feb-20-24 07:14AM
07:14AM Loading…
07:14AM
Jan-29-24 07:18AM
Jan-24-24 01:49PM
07:42AM
Jan-19-24 09:28AM
Jan-04-24 07:18AM
07:18AM
Dec-13-23 02:02PM
08:18AM
Dec-07-23 09:05AM
Dec-05-23 08:47AM
Dec-01-23 08:14AM
Nov-28-23 08:55AM
08:25AM
Nov-27-23 08:41AM
08:55AM Loading…
Nov-24-23 08:55AM
Nov-22-23 09:49AM
07:42AM
Nov-15-23 10:55AM
08:01AM
Nov-10-23 09:10AM
Oct-31-23 11:08AM
07:38AM
Oct-24-23 07:20AM
Oct-17-23 08:00AM
Oct-16-23 09:45AM
08:17AM
Oct-13-23 04:28PM
Oct-11-23 09:15AM
Oct-03-23 07:33AM
Sep-29-23 07:45AM
Sep-27-23 07:58AM
Sep-20-23 06:30AM
Sep-12-23 09:15AM
Sep-07-23 09:15AM
06:00AM
Aug-15-23 09:50AM
Aug-14-23 12:20PM
Aug-10-23 09:10AM
Aug-09-23 04:40PM
Aug-01-23 10:30AM
09:00AM
09:00AM
Jul-14-23 07:55AM
Jun-30-23 09:25AM
Jun-21-23 10:30AM
09:00AM
Jun-16-23 09:05AM
09:05AM
Jun-07-23 08:05AM
08:05AM
Jun-02-23 09:00AM
May-30-23 08:40AM
May-08-23 06:35AM
May-02-23 07:25AM
Apr-21-23 08:30AM
08:30AM
Apr-04-23 08:15AM
Mar-28-23 09:00AM
Mar-10-23 04:15PM
Mar-09-23 07:30AM
Mar-06-23 07:45AM
Feb-27-23 09:11AM
Feb-23-23 08:45AM
08:30AM
Feb-22-23 08:00AM
08:00AM
Feb-17-23 08:00AM
Feb-15-23 08:30AM
08:30AM
Jan-25-23 08:30AM
Jan-23-23 02:15PM
09:20AM
Jan-18-23 07:30AM
Jan-17-23 08:30AM
Jan-09-23 08:30AM
Jan-05-23 09:00AM
Dec-14-22 09:15AM
Dec-07-22 08:40AM
Nov-29-22 08:00AM
Nov-15-22 10:25AM
09:15AM
Nov-08-22 07:00AM
Nov-07-22 08:45AM
Nov-01-22 08:30AM
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.